Necrotizing Soft Tissue Infection Clinical Trial
Official title:
Demographic Characteristics, Symptoms, Treatment and Mortality of Patients With Necrotizing Soft Tissue Infections
To study the demographic characteristic of patients with necrotizing soft tissue infections.
At Aarhus University Hospital, Denmark, all patients with necrotizing soft tissue infections will be registered in a database in order to be able to describe their symptoms, demographic variables and thier treatment (surgery, time to surgery, antibiotics, intensive care unit, laboratory data etc). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT05157360 -
HAT for the Treatment of Sepsis Associated With NASTI
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT02314468 -
Negative Pressure Wound Therapy and Allogeneic Human Skin Grafts for Wound Bed Preparation
|
N/A | |
| Recruiting |
NCT05116956 -
SKin and Soft Tissue Necrotizing INfections in the Intensive Care Unit: a Prospective Multi-national Cohort Study
|
||
| Terminated |
NCT03403751 -
Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury
|
Phase 3 | |
| Terminated |
NCT05032625 -
To Evaluate the Outcomes After Surgery for Necrotizing Soft Tissue Infections
|
||
| Recruiting |
NCT05243966 -
Myriad™ Augmented Soft Tissue Reconstruction Registry
|
||
| Active, not recruiting |
NCT06126263 -
Adjunctive Clindamycin Versus Linezolid for β-lactam Treated Patients With Invasive Group A Streptococcal Infections
|
||
| Completed |
NCT02180906 -
Biomarkers in Patients With Flesh-eating Bacterial Infections
|
N/A | |
| Completed |
NCT03147352 -
Prognosis and Treatment of Necrotizing Soft Tissue Infections: A Prospective Cohort Study
|
||
| Completed |
NCT02501382 -
Modulation of Biomarkers in Patients With Flesh-eating Bacterial Infections After With Hyperbaric Oxygen Treatment
|
||
| Recruiting |
NCT06002607 -
Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
|
||
| Completed |
NCT02111161 -
Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial
|
Phase 2 | |
| Recruiting |
NCT03482245 -
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
|
N/A |